Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion ep...
Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells
About this item
Full title
Author / Creator
Publisher
Switzerland: Frontiers Research Foundation
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: Frontiers Research Foundation
Subjects
More information
Scope and Contents
Contents
Ischemic stroke is a debilitating disease for which there are currently no effective treatments besides the clot-buster, tissue plasminogen activator (t-PA), which is administered to less than 10% of patients due to a limited (4.5 h) time window of efficacy. Thus, there is an urgent need for novel therapies that can prevent or reverse the effects o...
Alternative Titles
Full title
Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_485b75b8a3eb406c975bbca5263c5cd4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_485b75b8a3eb406c975bbca5263c5cd4
Other Identifiers
ISSN
1662-5102
E-ISSN
1662-5102
DOI
10.3389/fncel.2012.00066
